Abstract Details
|
Jaishri Blakeley, MD, FAAN
(Johns Hopkins University School of Medicine)
PRESENTER |
Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Amanda Bergner (Ambry Genetics) | No disclosure on file |
| Alona Muzikansky | No disclosure on file |
| Vanessa Merker (Massachusetts General Hospital) | The institution of Vanessa Merker has received research support from Children's Tumor Foundation . The institution of Vanessa Merker has received research support from NF Northeast. The institution of Vanessa Merker has received research support from Patient Centered Outcomes Research Institute. The institution of Vanessa Merker has received research support from U.S. Department of Defense . The institution of Vanessa Merker has received research support from Neurofibromatosis Therapeutic Accleration Project. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a Science Writer with Neurofibromatosis Network. |
| Elizabeth R. Gerstner, MD | Dr. Gerstner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Midatech. Dr. Gerstner has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Gerstner Family Foundation. The institution of Dr. Gerstner has received research support from NCI. |
| No disclosure on file | |
| No disclosure on file | |
| Michael Jacobs, MD (University of California, Irvine) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Scott R. Plotkin, MD, PhD, FAAN (Mass General Cancer Center) | Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care. |